Blogs   -

Point of Care Diagnostics Market – High Prevalence of Chronic and Infectious Diseases is Expected to Lead the Market Growth – Growing at a Compound Annual Growth Rate (CAGR) 10.1% from 2022 to 2028

As stated in our extensive report; the Global Point of Care Diagnostics Market accounted for USD 41.5 Billion in the year 2021. 

The Point of Care Diagnostics Market growth is contributed by several factors such as the increasing number of infectious diseases, respiratory diseases, and covid-19 cases. Also, the improvised solutions and their increasing availability due to online platforms are predicted to grow in the forecasted period. 

The increasing number of infectious diseases contributes to Point of Care Diagnostics Market growth. Apart from rapidly growing covid cases, the diseases like HIV are also increasing as it is one of the most contagious diseases. A study report shows nearly 38.4 million people have been diagnosed with HIV in the past few 10;HIV-positive patients are expected to increase in the future. The increasing prevalence of HIV patients is expected to grow the demand for the Point of Care 10;Increasing demand is for Point of Care Diagnostics the expected to lead the Point of Care Diagnostics Market growth. 

The high prevalence of diabetes patients is another significant factor leading to the Point of Care Diagnostics Market. Furthermore, the high majority of Diabetics patients implies the growing requirement for blood glucose monitoring kits. Therefore, this application segment is expected to lead the market growth. On the other hand, the self-testing and home care segment is growing daily and is expected to lead the market growth in the forecasted period. 

The COVID-19 outbreak severely impacted the Point of Care Diagnostics Market as the supply chain was massively disrupted, and all the countries had to face a shortage of laboratory-based molecular assays. The Point of Care Diagnostics test is used to test the rapidly growing covid cases and is expected to gain momentum by the given number of covid cases diagnosed a crossed the globe. 

The regions such as are segmented to grow Point of Care Diagnostics 10; has dominated Point of Care Diagnostics Market in the past few 10;However, the is expected to grow Point of Care Diagnostics Market in the forecasted period owing to the increasing old age population that has a high probability of diabetics and other respiratory disorders and infectious diseases. 

The well-known players of the Global Point of Care Diagnostics Market include F. Hoffmann-La Roche Ltd., Qiagen, Danaher Corp., Becton Dickinson (BD), Biomerieux SA, Abbott Laboratories, Siemens Healthcare AG, Zoetis Inc., Instrumentation Laboratory, Nova Biomedical, Trividia Health Inc., Quidel Corp., Trinity Biotech, Sekisui Diagnostics, Orasure Technologies Inc., Nipro Corp., Spectral Medical Inc. and others.